Udiliv 150mg Tablet

Udiliv 150mg tablet consists of the active ingredient Ursodeoxycholic acid. It belongs to the group of medicines called Hepatoprotective agents. It is prescribed for liver and biliary conditions in case of cystic fibrosis and primary biliary cholangitis. Primary biliary cholangitis is a liver disorder where improper bile drainage damages liver tissues. Cystic fibrosis is an inherited liver and bile duct disease where the mucus in the body toughens and leads to clogging and inflammation. 

Don't take this tablet if you are allergic to Udiliv 150mg or any of the other ingredients of this medicine. Before starting this treatment, inform your doctor if you have an acute inflammation or non-functional gallbladder or a narrowing or blockage of the bile ducts and your history with gallbladder conditions. If you have a history of liver disease or obstruction in bile passage, your doctor may monitor your liver function every four weeks during the first three months of treatment. This monitoring would also enable early detection of acute live failure, especially in people with advanced primary biliary cholangitis.  

Before starting the treatment with Udiliv 150mg, notify your doctor if you have recently had surgery in any part of your intestine or hepatic encephalopathy (nervous system disorder caused by severe liver disorder) or if you have a liver bleeding disorder and any liver-related condition. Report to your doctor if you have any underlying kidney condition because there is limited information on the use of this tablet in patients with kidney disease. The common side effects of this tablet are pasty stool, diarrhea, rash, and abdominal pain.